Study provides a clear definition of late life homelessness

Homelessness among people over the age of 50 is on the rise, a phenomenon formal housing strategies often overlook — but researchers from the University of Toronto and McGill hope to prevent this oversight in the future.

ALK eyes label expansion after Phase III trial success – Pharmaceutical Technology

ALK plans to seek label expansion to include paediatric patients, with an expected paediatric launch in 2025. Image Credit: Sharomka / Shutterstock. ALK’s Itulatek, a

October 12, 2023

Medicover sees highest filings and grants during May in Q2 2024

Medicover has been focused on protecting inventions in United States(US) with two publications in Q2 2024 The United States(US) Patent Office dominates the patent filings

July 21, 2024

Intellia’s CRISPR-based treatment dramatically reduced patients’ swelling attacks in small trial

Intellia Therapeutics said Sunday that the first 10 patients to receive a CRISPR-based treatment for hereditary angioedema, a genetic disease, saw their swelling attacks —

June 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.